Essayer OR - Gratuit
Brand Loyalty at Risk as Buyers Chase Deal-Thrill
Mint Chennai
|January 27, 2025
While discounts drive immediate sales, they come at a significant cost. Brands that rely too heavily on price cuts risk diluting their value proposition
A few years ago, Neha Mathur, a loyal customer of a well-known beauty brand, wouldn't have thought twice before restocking her favourites, even at full price. But today, she's scrolling through multiple e-commerce platforms, hunting for the best deals. "I'll buy whichever brand is offering a discount. Why pay more when they're all the same?" she says.
Mathur isn't alone. Across India, consumers are increasingly trading brand allegiance for value, driven by a culture of discounts, cashback offers, and flash sales. This shift has left brands scrambling to retain loyalty in a market where price often outweighs everything else.
However, this narrative oversimplifies the evolving Indian consumer. As Shubhranshu Singh, chief marketing officer (CMO) of Tata Motors' commercial vehicles business, points out, "It is futile to talk about an 'average' Indian customer. India is incredibly diverse and heterogeneous. Its true value-consciousness is a common factor no matter whether the customer is looking for mass, popular, or premium goods or services. But remember, India is incredibly young—400 million Indians are not yet 20 years old."
This begs the question: Is the relentless focus on short-term wins eroding the foundations of long-term brand equity?
The rise of the deal-seeker
E-commerce giants like Amazon and Flipkart have reshaped shopping habits in India. Annual shopping events such as Amazon's Great Indian Sale and Flipkart's Big Billion Days have conditioned consumers to wait for discounts.
Cette histoire est tirée de l'édition January 27, 2025 de Mint Chennai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Chennai
Mint Chennai
Barrier-free tolling runs into a Chinese camera security bump
Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.
1 min
February 26, 2026
Mint Chennai
A new grammar to challenge Tamil film
Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham
3 mins
February 26, 2026
Mint Chennai
AUROBINDO PHARMA TAKES A PENICILLIN SHOT
The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?
6 mins
February 26, 2026
Mint Chennai
Digital rupee pilot for food subsidy
In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.
1 min
February 26, 2026
Mint Chennai
DRL's obesity jab may launch in March
Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.
1 min
February 26, 2026
Mint Chennai
Uranium supply deal likely during Carney’s India visit
Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM
2 mins
February 26, 2026
Mint Chennai
Warner interested in Paramount offer
Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.
1 mins
February 26, 2026
Mint Chennai
Hype and havoc shroud Al's impact on IT firms
Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why
2 mins
February 26, 2026
Mint Chennai
Zydus plans obesity jab in pens after semaglutide patent ends
Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.
1 mins
February 26, 2026
Mint Chennai
CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER
Most investors enter equity mutual funds expecting an annual average return of about 12%.
3 mins
February 26, 2026
Listen
Translate
Change font size

